Ragosa Mark bought KNSA
February 9, 2026 · Form 4 insider transaction
Ragosa Mark bought 8,374 shares of Kiniksa Pharmaceuticals International, plc at $12.97 per share, a transaction worth $108.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,374
Price
$12.97
Total value
$108.6K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after27,460
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.